|
1
|
Ghoncheh M, Pournamdar Z and Salehiniya H:
Incidence and mortality and epidemiology of breast cancer in the
world. Asian Pac J Cancer Prev. 17:43–46. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Howlader N, Noone AM, Krapcho M, Garshell
J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,
Mariotto A, et al: SEER Cancer Statistics Review, 1975-2012.
National Cancer Institute; Bethesda, MD: 2015, https://seer.cancer.gov/archive/csr/1975_2012/.
Accessed July 5, 2019.
|
|
3
|
Jung KW, Won YJ, Kong HJ, Oh CM, Cho H,
Lee DH and Lee KH: Cancer statistics in Korea: Incidence,
mortality, survival, and prevalence in 2012. Cancer Res Treat.
47:127–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oskarsson T: Extracellular matrix
components in breast cancer progression and metastasis. Breast.
22(Suppl 2): S66–S72. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Janicke F, Prechtl A, Thomssen C, Harbeck
N, Meisner C, Untch M, Sweep CG, Selbmann HK, Graeff H and Schmitt
M; German N0 Study Group: Randomized adjuvant chemotherapy trial in
high-risk, lymph node-negative breast cancer patients identified by
urokinase-type plasminogen activator and plasminogen activator
inhibitor type 1. J Natl Cancer Inst. 93:913–920. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kwon YS, Lee KS, Chun SY, Jang TJ and Nam
KS: Suppressive effects of a proton beam on tumor growth and lung
metastasis through the inhibition of metastatic gene expression in
4T1 orthotopic breast cancer model. Int J Oncol. 49:336–342. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee KS, Shin JS and Nam KS: Starfish
polysaccharides downregulate metastatic activity through the MAPK
signaling pathway in MCF-7 human breast cancer cells. Mol Biol Rep.
40:5959–5966. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li X, Kong X, Wang Y and Yang Q: BRCC2
inhibits breast cancer cell growth and metastasis in vitro and in
vivo via down-regulating AKT pathway. Cell Death Dis. 4:e7572013.
View Article : Google Scholar
|
|
9
|
Yang F, Hu M, Lei Q, Xia Y, Zhu Y, Song X,
Li Y, Jie H, Liu C, Xiong Y, et al: Nifuroxazide induces apoptosis
and impairs pulmonary metastasis in breast cancer model. Cell Death
Dis. 6:e17012015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Daniele A, Zito AF, Giannelli G, Divella
R, Asselti M, Mazzocca A, Paradiso A and Quaranta M: Expression of
metal-loproteinases MMP-2 and MMP-9 in sentinel lymph node and
serum of patients with metastatic and non-metastatic breast cancer.
Anticancer Res. 30:3521–3527. 2010.PubMed/NCBI
|
|
11
|
Choi JY, Jang YS, Min SY and Song JY:
Overexpression of MMP-9 and HIF-1α in breast cancer cells under
hypoxic conditions. J Breast Cancer. 14:88–95. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mehner C, Hockla A, Miller E, Ran S,
Radisky DC and Radisky ES: Tumor cell-produced matrix
metalloproteinase 9 (MMP-9) drives malignant progression and
metastasis of basal-like triple negative breast cancer. Oncotarget.
5:2736–2749. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moirangthem A, Bondhopadhyay B, Mukherjee
M, Bandyopadhyay A, Mukherjee N, Konar K, Bhattacharya S and Basu
A: Simultaneous knockdown of uPA and MMP9 can reduce breast cancer
progression by increasing cell-cell adhesion and modulating EMT
genes. Sci Rep. 6:219032016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harbeck N, Schmitt M, Kates RE, Kiechle M,
Zemzoum I, Jänicke F and Thomssen C: Clinical utility of
urokinase-type plasminogen activator and plasminogen activator
inhibitor-1 determination in primary breast cancer tissue for
individualized therapy concepts. Clin Breast Cancer. 3:196–200.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Look MP: Pooled analysis of uPA and PAI-1
for prognosis in primary breast cancer patients. EORTC receptor and
biomarker study group. Int J Biol Markers. 15:70–72. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sato H and Seiki M: Regulatory mechanism
of 92 kDa type IV collagenase gene expression which is associated
with invasiveness of tumor cells. Oncogene. 8:395–405.
1993.PubMed/NCBI
|
|
17
|
Takahra T, Smart DE, Oakley F and Mann DA:
Induction of myofibroblast MMP-9 transcription in three-dimensional
collagen I gel cultures: Regulation by NF-kappaB, AP-1 and Sp1. Int
J Biochem Cell Biol. 36:353–363. 2004. View Article : Google Scholar
|
|
18
|
Kim HS, Kim MJ, Kim EJ, Yang Y, Lee MS and
Lim JS: Berberine-induced AMPK activation inhibits the metastatic
potential of melanoma cells via reduction of ERK activity and COX-2
protein expression. Biochem Pharmacol. 83:385–394. 2012. View Article : Google Scholar
|
|
19
|
Kim S, Kim SH, Hur SM, Lee SK, Kim WW, Kim
JS, Kim JH, Choe JH, Nam SJ, Lee JE and Yang JH: Silibinin prevents
TPA-induced MMP-9 expression by down-regulation of COX-2 in human
breast cancer cells. J Ethnopharmacol. 126:252–257. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li CL, Yang D, Cao X, Wang F, Hong DY,
Wang J, Shen XC and Chen Y: Fibronectin induces
epithelial-mesenchymal transition in human breast cancer MCF-7
cells via activation of calpain. Oncol Lett. 13:3889–3895. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thant AA, Nawa A, Kikkawa F, Ichigotani Y,
Zhang Y, Sein TT, Amin AR and Hamaguchi M: Fibronectin activates
matrix metal-loproteinase-9 secretion via the MEK1-MAPK and the
PI3K-Akt pathways in ovarian cancer cells. Clin Exp Metastasis.
18:423–428. 2000. View Article : Google Scholar
|
|
22
|
Mierke CT, Frey B, Fellner M, Herrmann M
and Fabry B: Integrin α5β1 facilitates cancer cell invasion through
enhanced contractile forces. J Cell Sci. 124:369–383. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nam JM, Onodera Y, Bissell MJ and Park CC:
Breast cancer cells in three-dimensional culture display an
enhanced radio-response after coordinate targeting of integrin
alpha5beta1 and fibronectin. Cancer Res. 70:5238–5248. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wei PL, Kuo LJ, Huang MT, Ting WC, Ho YS,
Wang W, An J and Chang YJ: Nicotine enhances colon cancer cell
migration by induction of fibronectin. Ann Surg Oncol.
18:1782–1790. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kenny HA, Chiang CY, White EA, Schryver
EM, Habis M, Romero IL, Ladanyi A, Penicka CV, George J, Matlin K,
et al: Mesothelial cells promote early ovarian cancer metastasis
through fibronectin secretion. J Clin Invest. 124:4614–4628. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Knowles LM, Gurski LA, Engel C, Gnarra JR,
Maranchie JK and Pilch J: Integrin αvβ3 and fibronectin upregulate
Slug in cancer cells to promote clot invasion and metastasis.
Cancer Res. 73:6175–6184. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang JP and Hielscher A: Fibronectin: How
its aberrant expression in tumors may improve therapeutic
targeting. J Cancer. 8:674–682. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kang DG, Moon MK, Sohn EJ, Lee DH and Lee
HS: Effects of morin hydrate on blood pressure and metabolic
changes in fructose-induced hypertensive rats. Biol Pharm Bull.
27:1779–1783. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jung HJ, Kim SJ, Song YS, Park EH and Lim
CJ: Evaluation of the antiangiogenic, anti-inflammatory, and
antinociceptive activities of morin hydrate. Planta Med.
76:273–275. 2010. View Article : Google Scholar
|
|
30
|
Lee HS, Jung KH, Park IS, Kwon SW, Lee DH
and Hong SS: Protective effect of morin hydrate on
dimethylnitrosa-mine-induced hepatic fibrosis in rats. Dig Dis Sci.
54:782–788. 2009. View Article : Google Scholar
|
|
31
|
Jin H, Lee WS, Eun SY, Jung JH, Park HS,
Kim G, Choi YH, Ryu CH, Jung JM, Hong SC, et al: Morin hydrate, a
flavonoid from Moraceae, suppresses growth and invasion of the
highly metastatic breast cancer cell line MDA-MB-231 partly through
suppression of the Akt pathway. Int J Oncol. 45:1629–1637. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee YJ, Kim WI, Kim SY, Cho SW, Nam HS,
Lee SH and Cho MK: Flavonoid morin hydrate inhibits proliferation
and induces apoptosis of melanoma cells by regulating reactive
oxygen species, Sp1 and Mcl-1. Arch Pharm Res. 42:531–542. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim S, Chun SY, Lee DH, Lee KS and Nam KS:
Mineral-enriched deep-sea water inhibits the metastatic potential
of human breast cancer cell lines. Int J Oncol. 43:1691–1700. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Park SY, Kim YH, Kim Y and Lee SJ:
Aromatic-turmerone attenuates invasion and expression of MMP-9 and
COX-2 through inhibition of NF-κB activation in TPA-induced breast
cancer cells. J Cell Biochem. 113:3653–3662. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee SO, Jeong YJ, Im HG, Kim CH, Chang YC
and Lee IS: Silibinin suppresses PMA-induced MMP-9 expression by
blocking the AP-1 activation via MAPK signaling pathways in MCF-7
human breast carcinoma cells. Biochem Biophys Res Commun.
354:165–171. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li S, Lu J, Chen Y, Xiong N, Li L, Zhang
J, Yang H, Wu C, Zeng H and Liu Y: MCP-1-induced ERK/GSK-3β/Snail
signaling facilitates the epithelial-esenchymal transition and
promotes the migration of MCF-7 human breast carcinoma cells. Cell
Mol Immunol. 14:621–630. 2017. View Article : Google Scholar
|
|
37
|
Wang Y and Zhou BP: Epithelial-mesenchymal
transition-a hallmark of breast cancer metastasis. Cancer Hallm.
1:38–49. 2013. View Article : Google Scholar
|
|
38
|
Jin H, Yu Y, Zhang T, Zhou X, Zhou J, Jia
L, Wu Y, Zhou BP and Feng Y: Snail is critical for tumor growth and
metastasis of ovarian carcinoma. Int J Cancer. 126:2102–2111.
2010.
|
|
39
|
Mishra R: Glycogen synthase kinase 3 beta:
Can it be a target for oral cancer. Mol Cancer. 9:1442010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Luo J: Glycogen synthase kinase 3 beta
(GSK3 beta) in tumori-genesis and cancer chemotherapy. Cancer Lett.
273:194–200. 2009. View Article : Google Scholar
|
|
41
|
Weng CJ, Chau CF, Hsieh YS, Yang SF and
Yen GC: Lucidenic acid inhibits PMA-induced invasion of human
hepatoma cells through inactivating MAPK/ERK signal transduction
pathway and reducing binding activities of NF-kappa B and AP-1.
Carcinogenesis. 29:147–156. 2008. View Article : Google Scholar
|
|
42
|
Ma C, Wang J, Gao Y, Gao TW, Chen G, Bower
KA, Odetallah M, Ding M, Ke Z and Luo J: The role of glycogen
synthase kinase 3beta in the transformation of epidermal cells.
Cancer Res. 67:7756–7764. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Park SY, Kim YH, Kim Y and Lee SJ:
Frondoside A has an anti-invasive effect by inhibiting TPA-induced
MMP-9 activation via NF-κB and AP-1 signaling in human breast
cancer cells. Int J Oncol. 41:933–940. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cross DA, Alessi DR, Vandenheede JR,
McDowell HE, Hundal HS and Cohen P: The inhibition of
glycogen-synthase kinase-3 by insulin or insulin-like growth-factor
1 in the rat skeletal-muscle cell-line-L6 is blocked by wortmannin,
but not by rapamycin: Evidence that wortmannin blocks activation of
the mitogen-activated protein-kinase pathway in l6-cells between
Ras and Raf. Biochem J. 303:21–26. 1994. View Article : Google Scholar
|
|
45
|
Cross DA, Alessi DR, Cohen P, Andjelkovich
M and Hemmings BA: Inhibition of glycogen-synthase kinase-3 by
insulin-mediated by protein-kinase B. Nature. 378:785–789. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kim J, Montagne K, Nemoto H, Ushida T and
Furukawa KS: Hypergravity down-regulates c-fos gene expression via
ROCK/Rho-GTP and the PI3K signaling pathway in murine ATDC5
chondroprogenitor cells. PLos One. 12:e01853942017. View Article : Google Scholar : PubMed/NCBI
|
